Arthur H. Amron - 13 Dec 2023 Form 4 Insider Report for NEPHROS INC (NEPH)

Role: Director
Signature: /s/ Arthur H. Amron
Issuer symbol: NEPH
Transactions as of: 13 Dec 2023
Net transactions value: $0
Form type: 4
Filing time: 15 Dec 2023, 16:47:47 UTC
Previous filing: 08 Jun 2023
Next filing: 14 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NEPH	Common Stock	Award	$0	+9,291		$0.000000	9,291	13 Dec 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On December 13, 2023, the Company granted 9,291 shares of restricted stock of the Company (the "Restricted Stock") in lieu of cash fees payable to Mr. Amron in respect of his services as a member of the Board of Directors of the Company for 2023. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan (the "2015 Plan"). At the request of Mr. Amron, the Restricted Stock was granted to Wexford Capital LP. The Restricted Stock vests 6 months following the grant date.

Content

On December 13, 2023, the Company granted 9,291 shares of restricted stock of the Company (the "Restricted Stock") in lieu of cash fees payable to Mr. Amron in respect of his services as a member of the Board of Directors of the Company for 2023. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan (the "2015 Plan"). At the request of Mr. Amron, the Restricted Stock was granted to Wexford Capital LP. The Restricted Stock vests 6 months following the grant date.